Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
First-Line Durvalumab Plus Platinum-Etoposide Versus Platinum-Etoposide for Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis
PaperCitations, authors & open-access status
First-Line Durvalumab Plus Platinum-Etoposide Versus Platinum-Etoposide for Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 36 citations, 2020 year and gold oa status.
36
Citations
2020
Year
gold
OA Status